Menu

Image of Robert Vigersky, MD and Jane Reusch, MD

FEATURED EPISODE

Embracing AID and expanding therapy choices

Consensus recommendations encourage automated insulin delivery (AID) use in individuals with type 1 diabetes.1 But who is a good candidate for AID technology, and how can healthcare providers discuss AID system choice with people with type 1 diabetes?

Listen to episode (open in new window)

1 American Diabetes Association Professional Practice Committee; Diabetes Technology: Standards of Care in Diabetes—2025. Diabetes Care 1 January 2025; 48(Suppl. 1):S146-S166.

More episodes

Jennifer McVean, MD and Kristen Scavuzzo, MS, RD
EPISODE 9

Making life with diabetes easier

What is the burden that people living with diabetes carry? And how does diabetes technology, like automated insulin delivery (AID) systems, help minimize or decrease the daily burden for individuals living with T1D?

Bob Vigersky, MD and Amit Bhargava, MD
EPISODE 8

Automating therapy - Moving from MDI to AID

Despite technological advancements, many people with type 1 diabetes continue to utilize multiple daily injections. Learn how to successfully explain and start people living with type 1 diabetes on AID systems.

Bob Vigersky, MD and Kristen Scavuzzo, MS, RD
EPISODE 7

A1C vs GMI: which should you trust?

Glucose management indicator (GMI) is a CGM metric that shows the current state of a person's glucose management* and can help guide treatment adjustments. How is this metric calculated and how directly does it relate to A1C?

Jennifer McVean, MD and Ben Wheeler, MD
EPISODE 6

Automated insulin delivery in high-risk youth

This episode explores emerging research of the MiniMed™ 780G system in youth and young adults with elevated A1Cs.

View all episodes

Sign up for updates

This form is for healthcare professionals practicing in the United States only.
If you are a patient looking for more information click here.